Conversation with Dr. Corinna Mann

Dr. Corinna Mann – a specialist in gynecology, endocrinology, and reproductive medicine – unpacks the realities of infertility, age-related success rates across intrauterine insemination (IUI), in vitro fertilization (IVF), and intracytoplasmic sperm injection (ICSI), and the impact of truly personalized, empathetic care. We examine access and costs, employer-sponsored benefits, and why updating key regulations is overdue, plus the proactive role of social egg freezing. Tune in for a concise, insight-rich conversation on how personalization, prevention, and policy shape the future of health.

Conversation with Dr. Carlos Nunez

Join Dr. Carlos Nunez, Chief Medical Officer at Resmed, for an insightful exploration of the vital connection between sleep and overall health. This episode highlights the revolutionary impact of digital health technologies and AI in helping transform the diagnosis and treatment of sleep apnea – a condition affecting nearly a billion people worldwide, many of whom remain undiagnosed. Discover how heightened awareness and technological advancements are redefining sleep and breathing health, and how innovation is enhancing patient care and engagement.

Conversation with Prof. Dr. Urte Scholz and Prof. Dr. Claudia Witt

In this episode of the Strategy& Insider podcast, we explore the transformative role of behavioral science in healthcare with two distinguished experts from the University of Zurich and the University Hospital Zurich: Prof. Dr. Urte Scholz, a psychologist renowned for her work on health behavior change and stress management, joined by Prof. Dr. Claudia Witt, a physician and expert in digital health, mind-body medicine, and integrative oncology. They discuss how our daily habits and behaviors impact our long-term health, while exploring how using psychological principles in medical practices can improve patient care and management.

Conversation with Loren Larsen

In this episode of the Strategy& Insider podcast, we explore the transformative role of AI in mental healthcare with Loren Larsen, CEO and co-founder of Videra Health. Loren discusses how his innovative platform is revolutionizing mental health assessments by utilizing video, audio, and chat interactions to enhance patient outcomes and support clinicians. Tune in to explore how AI captures behavioral cues and emotional nuances, offering real-time insights that facilitate early detection and intervention. If you are interested in the future of healthcare technology and the potential of AI to expand access to mental health resources while reducing costs, this episode is a must-listen.

Conversation with Nitya Dintakurti

Join Nitya Dintakurti, the pioneering Founder and CEO of Unpause, as she transforms menopause support and women's health. In this episode, we explore the diverse challenges women face during this hormonal transition and how Unpause is reshaping the landscape with cutting-edge technology and innovation. Tune in for a captivating conversation on FemTech and the critical role of personalized and digitized approaches in advancing women's health outcomes.

Conversation with Prof. Dr. Robert Perneczky

This episode features Prof. Dr. Robert Perneczky who serves as Professor of Translational Dementia Research and Head of Geriatric Psychiatry at Ludwig-Maximilians University in Munich. Dive into the intricate realm of dementia and neurocognitive disorders as he reveals groundbreaking advancements in disease-modifying treatments and emphasizes the crucial role of lifestyle factors in mitigating dementia risk. Explore how cutting-edge innovations in biomarkers and interdisciplinary methodologies are revolutionizing the future of dementia care and gain insightful strategies to enhance resilience against neurodegeneration.

Conversation with Dr. Eicke Latz

Dr. Eicke Latz is a leading immunologist, Director of the German Rheumatology Research Center and Professor of Experimental Rheumatology at Charité Hospital in Berlin. In this episode, he offers valuable insights into his research on the innate immune system's role in maintaining health and its potential to promote disease. He explores the molecular mechanisms that activate or inhibit the immune system, impacting inflammation in diseases such as rheumatic disorders, arteriosclerosis, and Alzheimer's. Join us for an enlightening discussion on precision immuno-diagnostics and AI-driven medicine, which promise a future where targeted therapies address the root causes of diseases.

Conversation with Dr. Hadi Saleh

In this episode, Dr. Hadi Saleh, CEO of CeramTec, delves into the intricacies of navigating a shifting MedTech market with the rise of weight-loss blockbuster drugs as well as the influence of macroeconomic and geopolitical tensions on healthcare product development and innovation. The discussion also explores preventive care, the significance of a healthy lifestyle, and the potential of genetic editing and personalized medicine. Tune in for an engaging and informative conversation.

Conversation with Prof. Dr. Katarina Le Blanc and Dr. Mattias Bernow

In this episode, we welcome two trailblazers in the field of stem cell research: Join Prof. Dr. Katarina Le Blanc, a leading expert with over two decades of experience, as she shares her groundbreaking work with stem cells and how her research has contributed to the mission of making stem cell treatments and research more accessible through Cellcolabs. Accompanying her is Dr. Mattias Bernow, CEO of Cellcolabs, who brings a unique blend of medical and business expertise to the conversation, revealing strategies to make these revolutionary therapies affordable. Tune in to explore the transformative potential of stem cell research in disease care and prevention.

Conversation with Matthew Wood, MD, PhD

In this episode, we explore the forefront of rare disease research with Professor Matthew Wood, the Director and Chief Scientific Officer at the Oxford-Harrington Rare Disease Centre (OHC). Professor Wood shares his inspiring journey from his early studies in Cape Town to his impactful career at Oxford University. Learn about the innovative initiatives at OHC and their ambitious plan to bring 40 drugs into clinical trials within the next decade. This episode provides valuable insights into the challenges and opportunities in rare disease treatment, presenting a hopeful vision for rapid diagnosis and effective therapies.